Research method
Western Blot
A western blot separates proteins by electrophoresis, transfers them to a membrane, and detects a target with antibodies (or a tagged fusion). The output is a band whose size, abundance, or mobility shift reports presence, cleavage, ubiquitination, or glycosylation of that protein. A blot is not a subcellular map unless the sample was first fractionated, and antibody specificity is part of the result.
Molecular biologists use westerns when they need to know whether a protein is there, modified, or physically associated after a pull-down. It answers 'did this species change size or amount under this perturbation?' Its main limitation is that a band does not prove localisation or in-vivo dynamics, and some papers in this list use blots only as a supporting readout beside genetics, proximity labelling, or viral titres.
Evidence
What the evidence shows
Drawn from 12 studies in this library. Each finding starts with a plain-language takeaway, then the denser detail. Supports means evidence for a finding; Challenges means evidence against a stated position; Qualifies marks scope with a short note on each study’s contribution. Challenged positions are labeled — they are not findings.
Caveolar-coat purification used quantitative composition to show caveolins and cavins in one complex that excludes EHD2/pacsin 2, with Cavin 1 a core component and evidence for trimers. Western or blot-style detection of coat subunits supports stoichiometry; it is not a live-cell movie of every tissue's caveolae.
Tagged tobacco N and TMV p50 co-expressed in N. benthamiana associated in the cytoplasm; the TIR domain of N was critical for that association, and co-expression triggered hypersensitive-response cell death in two days. Domain mapping of a physical association is a classic immunoblot/co-IP use, not an atomic structure of the complex.
USP8 limits Smoothened ubiquitination: RNAi and biochemical readouts showed less ubiquitin on Smo, stronger Hedgehog signalling, and Hh-stimulated Smo–USP8 interaction. Ubiquitin blots here are a modification assay tied to trafficking, not a complete ligase identification.
SARS-CoV-2 spike LYQD mutants changed S2 glycosylation mobility, and palmitoylation at cysteine clusters I/II was required for efficient particle production, Golgi/plasma-membrane targeting, and ACE2-mediated fusion (2-bromopalmitate inhibition). Mobility shifts on S2 are a western-style glycosylation readout; much of the work uses spike pseudoviruses rather than full-virus genetics for every assay.
Not every tagged paper is a western-first study. APEX2 maps (22 OMM, 72 ERM proteins) are mass-spectrometry inventories; Wnt5a work uses purified ligand and receptor context to turn β-catenin–TCF signalling on or off; Cas13a plant antiviral work measures GFP and viral accumulation after targeting TuMV regions. Blots may appear as supporting assays, not as the experimental core.
- Mapping the faces of mitochondria and ER
- When does Wnt5a turn β-catenin signaling on or off?
- Can Cas13a fight RNA viruses in plants?
Study Role Design N Population Outcome Mapping the faces of mitochondria and ER Supports Animal / in-vitroAPEX2 proximity labeling of cytosol-facing OMM and ER membranes in living HEK 293T cells SILAC proteomic maps with two replicates per membrane — cell-resource study HEK 293T cells expressing OMM/ERM APEX2 fusions Proteomes of cytosol-facing outer mitochondrial and ER membranes When does Wnt5a turn β-catenin signaling on or off? Supports Animal / in-vitroPurified Wnt5a across receptor contexts testing canonical vs inhibitory outputs Receptor-context cell signaling assays — no single sample N Cells expressing Wnt receptors and responding to purified Wnt5a Context-dependent activation or inhibition of β-catenin–TCF signaling by Wnt5a Can Cas13a fight RNA viruses in plants? Supports Animal / in-vitroProgrammed Cas13a targeting TuMV genomic regions in plants Plant molecular interference assays — no single primary analytic N in stored text Plants infected with Turnip mosaic virus (TuMV) Cas13a-mediated reduction of viral GFP and accumulation
Open questions
Tensions and limits
Some items are genuine disagreements on the same question. Others mark different assays, populations, or outcomes — limits on how far one study travels — not a forced fight between papers.
Westerns here answer different biochemical questions. Caveolar work asks which subunits co-purify; N–p50 asks which domain is required for association and HR; USP8 asks whether Smo is ubiquitinated; spike work asks whether glycan occupancy and palmitoylation change S2 mobility and trafficking. A darker band is not a universal 'more protein' story across those designs.
- What proteins build the caveolar coat?
- Plant TIR domain binds viral elicitor
- How does USP8 turn on Smoothened?
- Spike glycosylation and palmitoylation trafficking
Study Role Design N Population Outcome What proteins build the caveolar coat? Supports Animal / in-vitroBiochemical purification and ultrastructure of caveolar coat proteins Structural/biochemical coat stoichiometry study — no single sample N Caveolar coat complexes (caveolins/cavins) Molecular composition and ultrastructure of the caveolar coat Plant TIR domain binds viral elicitor Supports Animal / in-vitroCo-expression domain mapping of N and TMV p50 in N. benthamiana Plant molecular genetics / protein-association assays — no single sample N Nicotiana benthamiana expressing tagged N and TMV p50 TIR-domain requirement for N–p50 association and HR cell death How does USP8 turn on Smoothened? Supports Animal / in-vitroRNAi screen of Drosophila DUBs in wings and S2 cells focused on USP8–Smo regulation Drosophila genetics and S2 cell assays — no single sample N Drosophila tissues and S2 cells USP8 prevention of Smoothened ubiquitination promoting Hedgehog signaling Spike glycosylation and palmitoylation trafficking Supports Animal / in-vitroMutagenesis and 2BP inhibition of SARS-CoV-2 spike glycosylation/palmitoylation trafficking Cell-based spike trafficking/fusion assays — no single primary analytic N Cells expressing wild-type or mutant SARS-CoV-2 spike Spike intracellular trafficking, packaging, and ACE2-mediated fusion APEX2, Wnt5a, and Cas13a illustrate false-positive or peripheral lexicon hits: proximity proteomics, ligand/receptor signalling, and CRISPR interference on an RNA virus. Citing them as if they were western-blot method papers overstates how the method was used.
- Mapping the faces of mitochondria and ER
- When does Wnt5a turn β-catenin signaling on or off?
- Can Cas13a fight RNA viruses in plants?
Study Role Design N Population Outcome Mapping the faces of mitochondria and ER Supports Animal / in-vitroAPEX2 proximity labeling of cytosol-facing OMM and ER membranes in living HEK 293T cells SILAC proteomic maps with two replicates per membrane — cell-resource study HEK 293T cells expressing OMM/ERM APEX2 fusions Proteomes of cytosol-facing outer mitochondrial and ER membranes When does Wnt5a turn β-catenin signaling on or off? Supports Animal / in-vitroPurified Wnt5a across receptor contexts testing canonical vs inhibitory outputs Receptor-context cell signaling assays — no single sample N Cells expressing Wnt receptors and responding to purified Wnt5a Context-dependent activation or inhibition of β-catenin–TCF signaling by Wnt5a Can Cas13a fight RNA viruses in plants? Supports Animal / in-vitroProgrammed Cas13a targeting TuMV genomic regions in plants Plant molecular interference assays — no single primary analytic N in stored text Plants infected with Turnip mosaic virus (TuMV) Cas13a-mediated reduction of viral GFP and accumulation
Common misconceptions
A mobility shift of spike S2 means the protein is more abundant.
LYQD mutants altered S2 glycosylation mobility — a size/glycan change — while palmitoylation at cysteine clusters I/II controlled trafficking and particle production. Mobility is not the same as band intensity.
If N's TIR domain binds TMV p50 on a blot, the atomic interface is solved.
Co-expression triggers HR in two days and the TIR domain is critical for association; the paper does not solve a full atomic structure of the N–p50 complex.
Caveolin–cavin co-detection on blots means EHD2 and pacsin 2 are in the same coat complex.
Quantitative composition found caveolins and cavins in one complex that excludes EHD2/pacsin 2. Co-purification defines the coat; it does not place every caveola-associated protein inside that core.
Exam-style questions
Short-answer questions that ask you to explain or compare, not recall.
Why can a glycosylation mobility shift of SARS-CoV-2 S2 and a ubiquitin smear on Smoothened both be 'western' results while answering different trafficking questions?
S2 mobility reports glycan occupancy after LYQD mutation; Smo ubiquitin blots report a post-translational mark that USP8 removes so Smo can reach the surface. Both are antibody/size readouts, but one is processing and the other is a degradative/trafficking modification.
N and p50 are cytoplasmic and HR appears in two days. What does a TIR-domain association blot add that the HR phenotype alone does not?
HR shows a death outcome of co-expression. The association assay shows a physical N–p50 interaction that requires the TIR domain, which HR timing alone cannot localise to a domain.
Caveolar composition excludes EHD2/pacsin 2. If a student sees those proteins on caveolae by microscopy, how do you reconcile the blot-based complex?
Microscopy can place proteins at the same structure; co-purification of a coat complex is stricter. Cavin 1 is core and trimeric in the biochemical model; EHD2/pacsin 2 can be caveola-associated without sitting in the caveolin–cavin coat.
Cas13a targeting of TuMV reduced GFP and viral accumulation. Why is that a weak example if you are studying western blot as a method?
The headline method is CRISPR/Cas13a interference on an RNA virus, with guide-region effects on GFP and viral load. Any blot is a supporting accumulation readout, not a protein-modification or co-IP study.
The studies
12 studies in this library bear on Western Blot, ordered by citations. The first 8 are shown.
- When does Wnt5a turn β-catenin signaling on or off?
Purified Wnt5a can activate or inhibit β-catenin–TCF signaling depending on which Frizzled/receptor context is present.
- Can Cas13a fight RNA viruses in plants?
CRISPR/Cas13a interferes with TuMV in plants, cutting viral RNA and reducing reporter/virus accumulation.
- Mapping the faces of mitochondria and ER
APEX2 proximity biotinylation yields high-quality proteomic maps of cytosol-facing outer mitochondrial and ER membranes in living human cells.
- How interferon throttles sterol synthesis in antiviral defense
Type I interferon couples viral sensing to down-regulation of the sterol pathway’s mevalonate–isoprenoid arm, limiting viral growth.
- Plant TIR domain binds viral elicitor
Tobacco N protein’s TIR domain is critical for association with TMV p50 elicitor.
- How do E. coli vesicles talk to gut epithelium?
Outer membrane vesicles from probiotic and commensal E. coli deliver ligands that activate NOD1-mediated immune responses in intestinal epithelial cells.
- What proteins build the caveolar coat?
Caveolins and cavins purify as a caveolar coat complex with Cavin 1 as a core trimeric component.
- How does USP8 turn on Smoothened?
USP8 deubiquitinates Smoothened, promoting Hh-dependent cell-surface accumulation and signaling while limiting early-endosome localization.
Show 4 more studiesShow fewer studies
- Histone acylations respond to plant stress
Rice histone butyrylation and crotonylation mark active chromatin and shift under starvation/submergence.
- How does ZFP36 reshape metabolism after growth signals?
Growth factors induce ZFP36, which binds and decays metabolic enzyme/transporter mRNAs—especially Eno2—tuning glycolytic metabolism.
- Folliculin tunes mTORC1 toward TFE3
FLCN–RagC signaling makes mTORC1 substrate-selective for TFE3 phosphorylation under amino-acid cues.
- Spike glycosylation and palmitoylation trafficking
Glycosylation motifs and cysteine palmitoylation steer SARS-CoV-2 spike maturation, Golgi trafficking, and fusion.
Learn alongside